Abstract
In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for thetopical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA)thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells in vitro. Topically applied nanogel creams carrying TMZ/PTX (4mg/1.5mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have